Contineum Therapeutics, Inc. (CTNM) Total liabilities 2023–2024
Contineum Therapeutics, Inc. (CTNM) total liabilities at each fiscal year-end, per SEC filings.
$14.8MFY2024 · since FY2023: $5.7M → $14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $14.8M | +159.2% |
| FY2023 | $5.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTNM financial trends
CTNM RevenueCTNM Net incomeCTNM Net marginCTNM Gross profitCTNM Gross marginCTNM Operating incomeCTNM Operating marginCTNM Operating cash flowCTNM Free cash flowCTNM Capital expendituresCTNM Return on equityCTNM Stock buybacksCTNM Dividends paidCTNM Total assetsCTNM Shareholders’ equityCTNM overview →